BridgeMD
New treatment option for Dementia Alzheimers
Official title Blood-based Biomarkers for Diagnosis of Alzheimer's
ClinicalTrials.gov ID: NCT05187819
What this study is testing
- What it's testing
- Alzheimer's disease (AD) may currently be diagnosed using molecular biomarkers in cerebrospinal fluid (CSF) and/or positron emission tomography (PET). These diagnostic procedures are highly accurate, but the high cost and low availability hamper their feasibility.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 100
You may be able to join if
- Participants suspected by their GP to have possible dementia, based on history, clinical examination and/or cognitive screening
You likely can't join if
- Lack of capacity for consent as judged by the GP.
- Severe psychiatric disease, use of medication or physical disease that according to the GP may affect participation or likely contribute...
- Patients not wanting to be referred to the memory outpatient clinic.
The study team makes the final eligibility decision.
Where it's taking place
- Stavanger, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stavanger, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.